Aminotetralin-derived urea modulators of vanilloid VR1 receptor
US8569505B2 · kind B2 · utility
4Cited by
5References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2010 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | Nov 9, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to β-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.